Sumanta Kumar Pal, MD, FASCO, joins Rohit Gosain, MD, and Rahul Gosain, MD, to discuss risk stratification and treatment practices for patients with localized kidney cancer following surgery.
First-Line Radiotherapy Combo May Show Benefit in Oligoprogressive HCC
First-line systemic therapy plus radiation therapy improved PFS vs second-line systemic therapy with or without radiation in hepatocellular carcinoma.
Beyond Surgery: The Evolving Landscape of Adjuvant Therapy in Kidney Cancer
Oncology Decoded hosts discuss adjuvant therapy in kidney cancer, including research, treatment strategies, and management of recurrence.
Machine Learning Approach May Predict Outcomes in RCC
A machine learning-based approach found that evaluating multiple biomarker features may identify outcomes and treatment resistance in renal cell carcinoma.
Adjuvant Therapy and Post-Surgical Management Options for Kidney Cancer
A recent Oncology Decoded podcast focuses on adjuvant therapy like pembrolizumab and optimal post-surgical care for patients with kidney cancer.
Outpatient Robotic Partial Nephrectomy Is Safe/Feasible for Renal Tumors
A prospective trial established that 97% of patients were successfully discharged on the same day as receiving robotic partial nephrectomy.
Belzutifan Improves Disease-Specific Symptoms/QOL vs Everolimus in RCC
Time to deterioration in physical functioning and role functioning was similar among those receiving belzutifan vs everolimus for renal cell carcinoma.